Cardiac Targeted Adeno-Associated Virus Injection in Rats
- PMID: 36040591
- DOI: 10.1007/978-1-0716-2707-5_10
Cardiac Targeted Adeno-Associated Virus Injection in Rats
Abstract
Gene therapy is a promising approach in the treatment of cardiovascular diseases. The vectors available for cardiovascular gene therapy have significantly improved over time. Cardiac tropism is a primary characteristic of an ideal vector along with a long-term expression profile and a minimal risk of cellular immune response. Preclinical and clinical studies have demonstrated that adeno-associated viral (AAV) vectors are one of the most attractive vehicles for gene transfer. AAV has gained great popularity in the last years because of its biological properties and advantages over other viral vector systems. In this chapter we will describe methods for intracardiac delivery of AAV vector in rats.
Keywords: Adeno-associated viral vector; Cardiac gene therapy; Cardiovascular diseases; Intracoronary administration; Intramyocardial administration.
© 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.
References
-
- Ylä-Herttuala S, Baker AH (2017) Cardiovascular gene therapy: past, present, and future. Mol Ther 25:1095–1106 - DOI
-
- Ishikawa K, Weber T, Hajjar RJ (2018) Human cardiac gene therapy. Circ Res 123:601–613 - DOI
-
- Katz MG, Fargnoli AS, Kendle AP et al (2016) Gene therapy in cardiac surgery: clinical trials, challenges, and perspectives. Ann Thorac Surg 101:2407–2416 - DOI
-
- Scimia MC, Gumpert AM, Koch WJ (2014) Cardiovascular gene therapy for myocardial infarction. Expert Opin Biol Ther 14:183–195 - DOI
-
- Katz MG, Fargnoli AS, Williams RD et al (2013) Gene therapy delivery systems for enhancing viral and nonviral vectors for cardiac diseases: current concepts and future applications. Hum Gene Ther 24:914–927 - DOI